Herein, we will review the development of thyroid hormones and synthetic thyromimetics based on TR selectivity for NAFLD, and analyze the role of TR-targeted drugs for the treatment of NAFLD in the future. Here, TG is linked to metabolic dysfunction-associated steatotic liver disease.